Literature DB >> 33357520

Long-Term Outcomes After PCI or CABG for Left Main Coronary Artery Disease According to Lesion Location.

Junho Hyun1, Ju Hyeon Kim1, Yeongjin Jeong1, KyungJin Choe1, Junghoon Lee1, Yujin Yang1, Tae Oh Kim1, Hanbit Park1, Sang-Cheol Cho1, Euihong Ko1, Do-Yoon Kang1, Pil Hyung Lee1, Jung-Min Ahn1, Seung-Jung Park1, Duk-Woo Park2.   

Abstract

OBJECTIVES: The aim of this study was to investigate the impact of lesion site (ostial or shaft vs. distal bifurcation) on long-term outcomes after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for left main coronary artery (LMCA) disease.
BACKGROUND: Long-term comparative data after PCI and CABG for LMCA disease according to lesion site are limited.
METHODS: Patients from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry were analyzed, comparing adverse outcomes (all-cause mortality [a composite outcome of death, Q-wave myocardial infarction, or stroke] and target vessel revascularization) between PCI and CABG according to LMCA lesion location during a median follow-up period of 12.0 years.
RESULTS: In overall population, the adjusted risks for death and serious composite outcome were higher after PCI than after CABG for distal bifurcation disease, which was mainly separated beyond 5 years. These outcomes were not different for ostial or shaft disease. When comparing drug-eluting stents (DES) and CABG, the adjusted risks for death and serious composite outcome progressively diverged beyond 5 years after DES compared with CABG for distal bifurcation disease (death: hazard ratio: 1.78; 95% confidence interval: 1.22 to 2.59; composite outcome: hazard ratio: 1.94; 95% confidence interval: 1.35 to 2.79). This difference was driven mainly by PCI with a 2-stent technique for distal bifurcation. In contrast, the adjusted risks for these outcomes were similar between DES and CABG for ostial or shaft disease.
CONCLUSIONS: Among patients with distal LMCA bifurcation disease, CABG showed lower mortality and serious composite outcome rates compared with DES beyond 5 years. However, there were no between-group differences in these outcomes among patients with ostial or shaft LMCA disease.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular events; coronary artery bypass grafting; left main coronary artery disease; mortality; percutaneous coronary intervention

Year:  2020        PMID: 33357520     DOI: 10.1016/j.jcin.2020.08.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  5 in total

Review 1.  PCI or CABG for Left Main Disease: Does Disease Location Matter?

Authors:  Manu Rajachandran; Rakhee Makhija
Journal:  Curr Cardiol Rep       Date:  2022-01-17       Impact factor: 2.931

Review 2.  The Current State of Coronary Revascularization: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery.

Authors:  Matthew A Brown; Seth Klusewitz; John Elefteriades; Lindsey Prescher
Journal:  Int J Angiol       Date:  2021-11-10

Review 3.  Left Main Coronary Artery Disease in Diabetics: Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting?

Authors:  Logan Disney; Chandrashekhar Ramaiah; Meghna Ramaiah; Suresh Keshavamurthy
Journal:  Int J Angiol       Date:  2021-08-31

4.  Perioperative variation in serum FGF-23 level and its correlation with MACCE risk in unprotected left main coronary artery disease patients receiving coronary artery bypassing grafting.

Authors:  Fanshun Wang; Runhua Ma; Chunsheng Wang
Journal:  Front Surg       Date:  2022-09-05

Review 5.  Left Main Coronary Artery Disease-Current Management and Future Perspectives.

Authors:  Emil Julian Dąbrowski; Marcin Kożuch; Sławomir Dobrzycki
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.